Rosalind Advisors, Inc.
CIK: 0001622627Latest portfolio: $284.5M · Q4 2025
Holdings
42
Total Value
$284.5M
New Positions
7
Closed Positions
4
Top Holdings
View All 42 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | DCTHDELCATH SYSTEMS, INC. | 3,300,389 | $33.0M | 11.60% | — | |
| 2 | YB4PSAVARA INC | 3,403,721 | $20.5M | 7.21% | -596,279 | |
| 3 | FRXFENNEC PHARMACEUTICALS INC | 2,613,508 | $20.1M | 7.07% | +537K | |
| 4 | XERSXERIS BIOPHARMA HOLDGS INC | 2,111,700 | $16.6M | 5.83% | +316K | |
| 5 | VRDNVIRIDIAN THERAPEUTICS INC | 450,000 | $14.0M | 4.92% | -150,000 | |
| 6 | MDWDMEDIWOUND LTD | 749,054 | $13.8M | 4.86% | — | |
| 7 | VSTMVERASTEM INC | 1,788,475 | $13.8M | 4.85% | -141,088 | |
| 8 | REPLREPLIMUNE GROUP INC | 1,410,497 | $13.7M | 4.82% | NEW | |
| 9 | ATYRASTRIA THERAPEUTICS INC | 1,039,080 | $13.6M | 4.78% | — | |
| 10 | HELPCYBIN INC | 1,657,540 | $13.6M | 4.77% | +158K | |
| 11 | EYPTEYEPOINT PHARMACEUTICALS INC | 690,000 | $12.6M | 4.43% | +40K | |
| 12 | CGONCG ONCOLOGY INC | 300,000 | $12.5M | 4.38% | — | |
| 13 | CYTKCYTOKINETICS INC | 195,045 | $12.4M | 4.36% | -204,955 | |
| 14 | XFORX4 PHARMACEUTICALS INC | 2,605,920 | $10.4M | 3.66% | +1.1M | |
| 15 | BRD1EURMIND MEDICINE MINDMED INC | 750,000 | $10.0M | 3.53% | — | |
| 16 | PRNPROFOUND MEDICAL CORP | 1,068,955 | $8.4M | 2.96% | +377K | |
| 17 | NSPRINSPIREMD INC | 3,905,743 | $7.0M | 2.44% | — | |
| 18 | OCULOcular Therapeutix, Inc | 400,000 | $4.9M | 1.71% | — | |
| 19 | AVBPARRIVENT BIOPHARMA INC | 215,871 | $4.3M | 1.53% | NEW | |
| 20 | TLPHTALPHERA INC | 3,579,273 | $4.1M | 1.43% | -806,484 | |
| 21 | MYOMYOMO INC | 3,839,772 | $3.5M | 1.23% | +49K | |
| 22 | QQQINVESCO QQQ TR | 450,000 | $3.0M | 1.06% | +200K | Put |
| 23 | PYPDPOLYPID LTD | 696,556 | $3.0M | 1.06% | -222,112 | |
| 24 | OKURONKURE THERAPEUTICS INC | 730,488 | $2.1M | 0.74% | NEW | |
| 25 | SPYSPDR S&P 500 ETF TR | 510,000 | $1.9M | 0.66% | +210K | Put |
Quarterly Changes
New Positions
Increased Positions
Sector Breakdown
Healthcare0.0% ($3.3003165761400417e+118T)
Unknown0.0% ($20524201241004.2T)
Financial Services0.0% ($841.2T)
Filing History
Fund Information
Rosalind Advisors, Inc. is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $284.5M across 42 holdings. The largest position is DELCATH SYSTEMS, INC. (DCTH), representing 11.6% of the portfolio. Compared to the previous quarter, the fund opened 11 new positions and closed 8 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.